Advair Hfa Aerosol, Metered
NDC Package 50090-4504-0
Package Information
Advair Hfa (fluticasone propionate and salmeterol xinafoate) aerosols is aDVAIR HFA is indicated for treatment of asthma in adult and adolescent patients aged 12 years and older. This formulation utilizes a aerosol, metered delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4504 and is authorized under FDA application NDA021254.
Identification & Billing
- RxCUI: 896244 - fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations
- RxCUI: 896244 - 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 896244 - fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- RxCUI: 896244 - fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- RxCUI: 896245 - ADVAIR HFA 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-4504 - Advair Hfa
- 50090-4504-0 - 1 INHALER in 1 CARTON / 120 AEROSOL, METERED in 1 INHALER
- 50090-4504 - Advair Hfa
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-4504-0 identifies a specific commercial package of 1 inhaler in 1 carton / 120 aerosol, metered in 1 inhaler of Advair Hfa, a human prescription drug labeled by A-s Medication Solutions. This aerosol, metered is formulated for respiratory (inhalation) use and contains fluticasone propionate; salmeterol xinafoate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on September 29, 2008. The current certification is valid through December 31, 2026.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090450400. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.